Exelon (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Exelon drug offered from Novartis Pharmaceuticals Corporation. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | rivastigmine |
| SUBSTANCE NAME: | RIVASTIGMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-07-06 |
| END MARKETING DATE: | 0000-00-00 |
Exelon HUMAN PRESCRIPTION DRUG Details:
| Item Description | Exelon from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4.6(mg/24h) |
| START MARKETING DATE: | 2007-07-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0501_66e21fca-01c4-4947-86ab-e6aea6b24f2c |
| PRODUCT NDC: | 0078-0501 |
| APPLICATION NUMBER: | NDA022083 |
Other RIVASTIGMINE Pharmaceutical Manufacturers / Labelers:
